Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.32%
EBIT Growth (5y)
3.29%
EBIT to Interest (avg)
24.60
Debt to EBITDA (avg)
1.18
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.79
Tax Ratio
31.47%
Dividend Payout Ratio
0
Pledged Shares
23.65%
Institutional Holding
41.11%
ROCE (avg)
13.54%
ROE (avg)
9.95%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
34
Price to Book Value
2.18
EV to EBIT
15.92
EV to EBITDA
11.76
EV to Capital Employed
2.26
EV to Sales
2.38
PEG Ratio
8.57
Dividend Yield
0.28%
ROCE (Latest)
14.23%
ROE (Latest)
9.37%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 9,870.29 cr
DEBT-EQUITY RATIO(HY)
Lowest at 0.21 times
NET SALES(Q)
Highest at Rs 8,853.34 cr
EPS(Q)
Highest at Rs 15.86
-5What is not working for the Company
ROCE(HY)
Lowest at 12.10%
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.71 times
OPERATING PROFIT TO NET SALES (Q)
Lowest at 19.80%
Loading Valuation Snapshot...
Here's what is working for Aurobindo Pharma
Net Sales - Quarterly
Highest at Rs 8,853.34 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 15.86
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 9,870.29 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio - Half Yearly
Lowest at 0.21 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Aurobindo Pharma
Operating Profit Margin - Quarterly
Lowest at 19.80%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Debtors Turnover Ratio- Half Yearly
Lowest at 4.71 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
